It is well known that pharmaceutical companies have almost a bizarre mixture of units in which some are on cutting edge of science and technologies while other units are extremely slow to adopt and utilize new solutions. This slow pace is particularly prevalent in the support of clinical trials. Companies have been historically slow to adopt new technologies, a prime example being Electronic Data Capture. First commercial systems became available in the 1980’s and widespread adoption really did...
